Follow up Protocol to the Phase I/II Study of OPN-305 in Second-line or Third-line Lower Lower Risk Myelodysplastic Syndrome Read more about Follow up Protocol to the Phase I/II Study of OPN-305 in Second-line or Third-line Lower Lower Risk Myelodysplastic Syndrome
A Study to Assess the Efficacy and Safety of BIVV009 (Sutimlimab) in Participants With Primary Cold Agglutinin Disease Without A Recent History of Blood Transfusion Read more about A Study to Assess the Efficacy and Safety of BIVV009 (Sutimlimab) in Participants With Primary Cold Agglutinin Disease Without A Recent History of Blood Transfusion
A Study to Assess the Efficacy and Safety of BIVV009 (Sutimlimab) in Participants With Primary Cold Agglutinin Disease Who Have a Recent History of Blood Transfusion (Cardinal Study) Read more about A Study to Assess the Efficacy and Safety of BIVV009 (Sutimlimab) in Participants With Primary Cold Agglutinin Disease Who Have a Recent History of Blood Transfusion (Cardinal Study)
Safety, Tolerability and Pharmacokinetics of MRG-106 in Patients With Mycosis Fungoides (MF), CLL, DLBCL or ATLL Read more about Safety, Tolerability and Pharmacokinetics of MRG-106 in Patients With Mycosis Fungoides (MF), CLL, DLBCL or ATLL
Study of Voicing My CHOiCES as a Tool for Advanced Care Planning in Young Adults With Cancer Read more about Study of Voicing My CHOiCES as a Tool for Advanced Care Planning in Young Adults With Cancer
Phase I/II Study of Avelumab in Pediatric Cancer Subjects Read more about Phase I/II Study of Avelumab in Pediatric Cancer Subjects
PD-1 Inhibition in Advanced Myeloproliferative Neoplasms Read more about PD-1 Inhibition in Advanced Myeloproliferative Neoplasms
A Study of Acute Myocardial Infarction Using FDY-5301 Read more about A Study of Acute Myocardial Infarction Using FDY-5301
Strategic Management to Improve CRT Using Multi-Site Pacing Post Approval Study (Reference # C1918) Read more about Strategic Management to Improve CRT Using Multi-Site Pacing Post Approval Study (Reference # C1918)